In AD and ACLF patients, CXCL1 and CXCL8 levels are highly elevated, even compared with those in patients with compensated cirrhosis [148, 149]; however, impaired neutrophil migration persists and is associated with adverse outcomes in these cohorts [150]. This evidence concerns the gene CXCL8 and Cirrhosis.